Related Experiment Video
Updated: Jul 15, 2026

RNA Catalyst as a Reporter for Screening Drugs against RNA Editing in Trypanosomes
Published on: July 22, 2014
Oxetane-to-azetidine skeletal editing
Dayu Tian1, Like Luo1, Xian Xiao1
1State Key Laboratory of Precision and Intelligent Chemistry, Department of Chemistry, University of Science and Technology of China, Hefei, China.
Abstract:
The identity of heteroatoms within bioactive molecules can profoundly influence their physicochemical and biological properties. Evaluating heterocycle analogues featuring distinct heteroatoms for new therapeutic opportunities, however, often requires laborious de novo syntheses. Here we report a straightforward, two-step, one-pot strategy for the direct skeletal editing of readily available oxetanes into azetidines using a broad range of aromatic and aliphatic amines. This transformation proceeds under simple conditions through Lewis acid-mediated intermolecular aminolysis of oxetanes, followed by an intramolecular Mitsunobu-type dehydrative cyclization to forge the azetidine ring. The resulting non-redox skeletal editing platform features broad substrate scope, excellent functional group tolerance and compatibility with complex, drug-like molecules, enabling rapid access to azetidine analogues from oxetane precursors for heterocycle editing in drug discovery.
Related Concept Videos
RNA Editing
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Preparation of 1° Amines: Azide Synthesis
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
Bone Remodeling
Alkynes to Carboxylic Acids: Oxidative Cleavage

